Healthcare IT Today June 20, 2024
Akili to Operate as Wholly Owned Subsidiary of Virtual Therapeutics
Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc., a leading digital therapeutics company, today announced the signing of a definitive merger agreement to form a diversified, leading digital health company.
Under the terms of the agreement, Akili shareholders will receive $0.4340 per share of common stock in cash. The per share purchase price represents an approximately 4% premium to Akili’s closing stock price on May 28, 2024 and an approximately 85% premium to Akili’s closing price on April 29, 2024, the last trading day prior to Akili’s public announcement that it was evaluating potential strategic alternatives. Following completion of the...
Today's Sponsors
Today's Sponsor